Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abbott, accrete, Ackermann, acquiree, aim, alcohol, Aldrich, ALE, Allete, analyst, Andela, annum, antimicrobial, Arena, arose, Art, AST, Atlantic, attended, attrition, automation, Axon, Bachelor, background, banker, Becton, Bexcom, bifurcated, Bioengineering, Biographical, biomedical, biotech, Boston, Brown, CEO, chair, chromosome, citizen, clerical, COBRA, color, Colorado, Columbia, column, Commissioner, commodity, compatible, construe, contendere, conviction, crime, death, debenture, deep, defibrillator, dengue, detriment, detrimental, Dickinson, digital, Dillon, discharge, dishonesty, doctor, domiciled, driver, ECFMG, EDGAR, EMD, empowering, energy, entrepreneur, epidemic, equitable, erroneously, Excellence, exhaustive, factory, FDIC, fellow, felony, fifty, Fleet, flexibility, FMV, founder, Fractional, Francisco, fuel, gauge, Geffen, Genentech, Genyzyme, George, Goldman, Guidant, Hambrecht, Head, hereunder, host, Humanigen, hypothetical, IIA, Immunology, incentivize, incorrect, inflationary, instill, invaded, Israeli, IVDR, Jefferson, joined, joining, Jose, Jude, KGaA, Konrad, Lawrence, LGND, lieu, Ligand, lived, loading, Marshall, Martin, mathematical, MBA, media, membership, Michigan, midyear, military, MIT, MMM, Montgomery, moral, mortality, MTS, MTSC, nanomolar, nanosynex, narrative, Naval, Navy, nearest, NeuroCircuit, NIS, nolo, NYSE, ODD, oligonucleotide, oncologist, opine, overseeing, overseen, owner, pan, Pasteur, PDUFA, peer, PEO, percent, perspicuity, Pfizer, PhD, Philadelphia, philosophy, phosphoprotein, plea, POL, prefunded, premedical, premier, print, Prison, Professor, proforma, Punjab, purport, PVP, Quist, rationale, rebound, recession, refinance, rental, repatriation, repetitive, reprice, repriced, repricing, repurchase, repurchased, resignation, retention, RSU, RSV, San, Sanofi, SAR, School, SCT, Searle, sense, Serono, Shekel, Sigma, Silicon, Sloan, software, spent, spouse, St, staffing, Stanford, subsided, successor, sudden, surgery, surrendered, SVB, SynergenX, talent, talented, tangible, taxation, television, tenure, theft, TNBC, trajectory, transportation, trust, turpitude, UCLA, unchanged, uncured, undergraduate, underwritten, unpaid, urology, USA, USD, Valley, vehicle, Ventritex, vi, Vietnam, vii, viii, Viking, vital, vivo, VKTX, voluntarily, withheld, withholding, WR, xenograft, XOMA, Ziona
Removed:
acquirer, adjust, anticipation, behalf, biology, call, clear, comparative, comparison, confirming, correct, deficiency, discontinued, earliest, electronic, emerged, Extensible, extinguishment, Finally, grace, hereof, herewith, hindsight, inadvertently, interrupt, introduced, Japan, judgement, Korea, Language, lawfully, merit, notifying, omitted, opening, partnering, payroll, physical, predicted, ratifying, refusal, representing, restate, restrictive, retrospective, revised, ROU, space, stringent, stronger, substitution, Subtopic, task, thereto, thereunto, therewith, trademark, undersigned, virtue, vitro, XBRL
Filing tables
Filing exhibits
QLGN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF BAKER TILLY US, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-266430 and 333-269088) and Form S-8 (File No. 333-220907, 333-249280, 333-249281 and 333-262090) of Qualigen Therapeutics, Inc. of our report dated May 2, 2023, relating to the consolidated financial statements, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern and appears on page 38 of this annual report on Form 10-K for the year ended December 31, 2022.
/s/ BAKER TILLY US, LLP | |
San Diego, CA | |
May 2, 2023 |